|
RRM2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.321400E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.057800E-01 |
| Normal-vs-Stage2 |
9.948200E-02 |
| Normal-vs-Stage3 |
6.033000E-01 |
| Normal-vs-Stage4 |
7.875800E-01 |
| Stage1-vs-Stage2 |
6.04610000000116E-05 |
| Stage1-vs-Stage3 |
2.953200E-01 |
| Stage1-vs-Stage4 |
4.881000E-01 |
| Stage2-vs-Stage3 |
6.984400E-03 |
| Stage2-vs-Stage4 |
1.979530E-03 |
| Stage3-vs-Stage4 |
1.907360E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.444600E-01 |
| Normal-vs-AfricanAmerican |
6.483600E-01 |
| Normal-vs-Asian |
6.878400E-01 |
| Caucasian-vs-AfricanAmerican |
5.666000E-01 |
| Caucasian-vs-Asian |
4.730800E-01 |
| AfricanAmerican-vs-Asian |
8.899800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.903200E-01 |
| Normal-vs-Female |
7.150600E-01 |
| Male-vs-Female |
8.085600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.924600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.426600E-01 |
| Normal-vs-Age(61-80Yrs) |
8.010000E-01 |
| Normal-vs-Age(81-100Yrs) |
3.754800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.168970E-04 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.163000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.693770E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.729500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.544100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.092820E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
7.233800E-01 |
| Classical-VS-Follicular |
1.81115999999815E-05 |
| Classical-VS-Other |
1.085970E-01 |
| Classical-VS-Normal |
9.954600E-01 |
| Tall-VS-Follicular |
2.923900E-03 |
| Tall-VS-Other |
1.208970E-01 |
| Tall-VS-Normal |
8.319600E-01 |
| Follicular-VS-Other |
6.112200E-01 |
| Follicular-VS-Normal |
1.124970E-01 |
| Other-VS-Normal |
3.328800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.972400E-01 |
| Normal-vs-N1 |
6.116200E-01 |
| N0-vs-N1 |
7.448400E-01 |
|
|
